SPY751.74−0.71%QQQ676.88−1.64%BTC/USD68,922.65−3.43%DIA522.20−0.05%GLD356.19+0.37%TLT79.48−0.31%

Nurix Therapeutics Inc

NRIXNASDAQ

Trade with Public

$15.68

0.0750.48%

Last update: Nov 13, 12:39 PM

Overview News Charts Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Options Stock Report

Nurix Therapeutics (NRIX) Stock Price Target 2026

See analyst price targets, ratings and recent upgrades and downgrades for Nurix Therapeutics (NRIX) stock.

Analyst Consensus — 18 Analysts

17Buy

1Hold

# Analysts18

Latest Upgrades and Downgrades for Nurix Therapeutics Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
—	Wells Fargo	Derek Archila	PT Cut	Equal-Weight	$25→$20
—	HC Wainwright & Co.	Robert Burns	PT Raise	Buy	$34→$36
—	RBC Capital	Brian Abrahams	PT Cut	Outperform	$36→$35
—	Oppenheimer	Kostas Biliouris	PT Raise	Outperform	$28→$32
—	Truist Securities	Gregory Renza	PT Cut	Buy	$34→$33
—	Baird	Joel Beatty	PT Raise	Outperform	$33→$36
—	Needham	Gil Blum	Maintained	Buy	$34
—	RBC Capital	Brian Abrahams	PT Raise	Outperform	$33→$36
—	Needham	Gil Blum	Maintained	Buy	$34
—	Morgan Stanley	Terence Flynn	PT Raise	Overweight	$36→$38
—	UBS	David Dai	PT Raise	Buy	$23→$31
—	Mizuho	Joseph Catanzaro	PT Raise	Outperform	$30→$34
—	Truist Securities	Gregory Renza	PT Raise	Buy	$32→$34
—	RBC Capital	Brian Abrahams	PT Raise	Outperform	$30→$33
—	Stifel	Stephen Willey	PT Raise	Buy	$34→$40
—	BTIG	Jeet Mukherjee	Maintained	Buy	$32
—	Needham	Gil Blum	Maintained	Buy	$34
—	HC Wainwright & Co.	Robert Burns	PT Raise	Buy	$32→$34
—	Baird	Joel Beatty	PT Raise	Outperform	$26→$33
—	Needham	Gil Blum	Maintained	Buy	$34

Nurix Therapeutics Inc

Nurix Therapeutics (NRIX) Stock Price Target 2026

Latest Upgrades and Downgrades for Nurix Therapeutics Stock

Nurix Therapeutics (NRIX) Stock Price Target 2026

Latest Upgrades and Downgrades for Nurix Therapeutics Stock

Analyst Ratings News

PRO
Wells Fargo Maintains Equal-Weight on Nurix Therapeutics, Lowers Price Target to $20

SpaceX To Rally Around 85%? Here Are 10 Top Analyst Forecasts For Friday

PRO
HC Wainwright & Co. Maintains Buy on Nurix Therapeutics, Raises Price Target to $36

PRO
RBC Capital Maintains Outperform on Nurix Therapeutics, Lowers Price Target to $35

PRO
Oppenheimer Maintains Outperform on Nurix Therapeutics, Raises Price Target to $32

PRO
Truist Securities Maintains Buy on Nurix Therapeutics, Lowers Price Target to $33

People Also Watch

People Also Watch

Analyst Ratings News

PRO
Wells Fargo Maintains Equal-Weight on Nurix Therapeutics, Lowers Price Target to $20

SpaceX To Rally Around 85%? Here Are 10 Top Analyst Forecasts For Friday

PRO
HC Wainwright & Co. Maintains Buy on Nurix Therapeutics, Raises Price Target to $36

PRO
RBC Capital Maintains Outperform on Nurix Therapeutics, Lowers Price Target to $35

PRO
Oppenheimer Maintains Outperform on Nurix Therapeutics, Raises Price Target to $32

PRO
Truist Securities Maintains Buy on Nurix Therapeutics, Lowers Price Target to $33

Nurix Therapeutics Inc

Nurix Therapeutics (NRIX) Stock Price Target 2026

Latest Upgrades and Downgrades for Nurix Therapeutics Stock

Nurix Therapeutics (NRIX) Stock Price Target 2026

Latest Upgrades and Downgrades for Nurix Therapeutics Stock

Analyst Ratings News

PROWells Fargo Maintains Equal-Weight on Nurix Therapeutics, Lowers Price Target to $20

SpaceX To Rally Around 85%? Here Are 10 Top Analyst Forecasts For Friday

PROHC Wainwright & Co. Maintains Buy on Nurix Therapeutics, Raises Price Target to $36

PRORBC Capital Maintains Outperform on Nurix Therapeutics, Lowers Price Target to $35

PROOppenheimer Maintains Outperform on Nurix Therapeutics, Raises Price Target to $32

PROTruist Securities Maintains Buy on Nurix Therapeutics, Lowers Price Target to $33

People Also Watch

People Also Watch

Analyst Ratings News

PROWells Fargo Maintains Equal-Weight on Nurix Therapeutics, Lowers Price Target to $20

SpaceX To Rally Around 85%? Here Are 10 Top Analyst Forecasts For Friday

PROHC Wainwright & Co. Maintains Buy on Nurix Therapeutics, Raises Price Target to $36

PRORBC Capital Maintains Outperform on Nurix Therapeutics, Lowers Price Target to $35

PROOppenheimer Maintains Outperform on Nurix Therapeutics, Raises Price Target to $32

PROTruist Securities Maintains Buy on Nurix Therapeutics, Lowers Price Target to $33

PRO
Wells Fargo Maintains Equal-Weight on Nurix Therapeutics, Lowers Price Target to $20

PRO
HC Wainwright & Co. Maintains Buy on Nurix Therapeutics, Raises Price Target to $36

PRO
RBC Capital Maintains Outperform on Nurix Therapeutics, Lowers Price Target to $35

PRO
Oppenheimer Maintains Outperform on Nurix Therapeutics, Raises Price Target to $32

PRO
Truist Securities Maintains Buy on Nurix Therapeutics, Lowers Price Target to $33

PRO
Wells Fargo Maintains Equal-Weight on Nurix Therapeutics, Lowers Price Target to $20

PRO
HC Wainwright & Co. Maintains Buy on Nurix Therapeutics, Raises Price Target to $36

PRO
RBC Capital Maintains Outperform on Nurix Therapeutics, Lowers Price Target to $35

PRO
Oppenheimer Maintains Outperform on Nurix Therapeutics, Raises Price Target to $32

PRO
Truist Securities Maintains Buy on Nurix Therapeutics, Lowers Price Target to $33